Legacy Bridge, LLC Novo Cure LTD Transaction History

Legacy Bridge, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 17, 2024	SELL	$11.13 - $15.78 $834 - $1,183	-75 Reduced 15.79%	400 $5,000
Q3 2023 Oct 11, 2023	SELL	$16.15 - $42.35 $1,211 - $3,176	-75 Reduced 13.64%	475 $7,000
Q1 2020 Apr 09, 2020	BUY	$57.05 - $95.75 $5,134 - $8,617	90 Added 19.57%	550 $37,000
Q3 2019 Oct 15, 2019	BUY	$61.86 - $97.8 $24,744 - $39,120	400 Added 666.67%	460 $34,000
Q2 2019 Jul 11, 2019	BUY	$42.22 - $63.23 $2,533 - $3,793	60 New	60 $4,000

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.16B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Legacy Bridge, LLC, based on Form 13F filings with the SEC.

Stay updated on Legacy Bridge, LLC with notifications on news.